<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 48 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page47.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=48">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 48 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 48</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=48"><img src="../thumb/48.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Central Nervous System - 1.4.4                                                  2020-04 / 17
       vis.of poss.suicide pts.esp. init.& dur.dos.chang., monit.prothromb.  (drug metabol. induc.), hepat.cytochrome P450 isozyme CYP2D6 re-  Side-effects: Seiz., GI disturbs., CNS effs, trem., incr. sweat., dry mouth,
       time when ther.init./stop., monit.concom. Li lev.as incid.of seroton.   spons.for metabol.of debrisoquine & sparteine is inhibited enhanc.   sex.dysfunct., palpitat., chest pain, hypertens., syncope, tachycard., par-
       assoc.S/E incr., adeq.contracept.in women of childbear.potent., ta-  plasma lev.of concom.meds.metabol.by this isoenzyme., poss.sero-  aesthes., hypoaesthes., twitch., hyperton., skin rash, fatig., hot flushes,
       per dos.dur.discont., worsen.depress./emerg.suicide ideat./-behav   ton.syndr.with tryptophan, incr. incid.of adverse effs.with anti-con-  fev., back pain, anaphylact.react., angioed., thirst, gynaecomast., hyper-
       risk in maj. depress./other psych./non-psych.disords., monit. pts.  vuls.& sumatriptan, incr.procyclidine plasma lev.& other anti-cho-  prolactinaem., galactorrh., hypothyroid., SIADH, myalg., arthralg., psych.
       esp.dur early ther.& dos changes for clinic.worsen./suicid.ideat./  linergs., poss.incr.bleed.in pres.of unalt.prothrob.times with warfar,   disords., menstr. sympts., rhinit., pharyngit., bronchosp., vis. disturbs., tin-
       behav., hostility /suicid.ideat.& self harm report.in childr., monit. pts.   theophylline lev.poss.elev.  nit., taste pervers., micturit.freq/ disords., alt.platelet funct., bld.dyscras.,
       with extrapyramid.disords., switch.from other antidepress./anti-ob-  extrapyramid. sympts., Parkinson’s aggrav., hyponatraem.
       session.esp.long act.agents, consid.chang.therapeut.regim/discont.if   SERTRA, Pfizer [P/S]  Special precautions: Use for more than 12 wks. not eval.in panic
       psych. sympts. occur which are sev./abrupt in onset/not part of pres.   Sertraline HCl.  disord., re-eval.pt.in long term use, poss.activat.of mania/hypoman.,
       sympts., monit.prot.bound meds.  Indications: Maj.depress.disords.such as sngl. episod. & recurr.  poss. signific.weight loss, avoid in unstable epilep, monit.control.epi-
       Drug interactions: Signific.chang.in some pharmacokinet. paramet.  depress., obsess.compuls.disord., panic disord.with/-out agoraphob.  lept., discont.if seiz.develop, close supervis.of poss.suicide pts., uric
       with diazepam & tolbutamide, cimetidine decr.clear., incr.in prothrom-  (S5) TABS, A39/1.2/0308  acid ser. lev.decr., risks/benefits of concom.ECT ther.not est., dis./
       bin time with warfar, meds.metabol.by cytochrome P-450 CYP2D6,   715350-001: 50 mg, 30, R166,96  condits.affect.metabol./ haemodynam. respons., not eval./used with
       ser.somet.fatal reacts. with MAOI.  Dosage: Admin as sngl.dly.dos.  MI/unstab.heart dis., ren./liv.impairm., worsen.depress./emerg. sui-
                                     Depress: Init. 50 mg dly. Usual therap.dos.50 mg dly. May be titr.up   cide ideat./-behav risk in maj.depress./other psych./non-psych.dis-
       SERLIFE, Ranbaxy [P/S]        in 50 mg increm.at 2 wk. interv. to max.150-200 mg.  ords., monit.pts.esp.dur early ther.& dos changes for clinic.worsen./
       Sertraline HCl.               OCD: Eff.may be seen with.7 days. Full activ.usual. seen aft.   suicid. ideat./behav., consid.chang.therapeut. regim/discont.if psych.
       Indications: Maj.depress.disords.such as sngl. episod. & recurr.  2-4 wks.or long. Min.effect.dos. 50 mg dly. Incr.above 100 mg dly   sympts.occur which are sev./abrupt in onset/not part of pres.sympts.,
       depress., obsess.compuls.dis.  have no addit.benef.        taper dos.dur.discont., concom.anticoags./meds affect.platelet funct./
       (S5) TABS, 36/1.2/0272, 0273  Panic disord: Min.recomm.effect.dos: 50 mg dly. Init. 25 mg dly.  TCA’s/acetylsalicyl.acid/ NSAID’S/atypic.antipsychot. & phenothiaz.,
       703132-001: 50 mg, 30, R96,82  incr.to 50 mg dly.aft.1 wk. This regim.reduc.freq.of early treatm.  bleed. disords., switch.from other antidepress./ anti-obsession.esp.
       703999-001: 100 mg, 30, R121,89  emergent.S/E.             long act.agents, monit.prot. bound meds., monit.concom Li lev.as high.
       Dosage: Admin as sngl.dly.dos.  Contraindications: MAOI incl.linezolid, concom. pimozide, ren./  incid. of 5HTassoc.S/E, concom.sumatriptan, monit. bld.gluc.in diabet.
       Depress: Init. 50 mg dly. Usual therapeut.dos. 50 mg dly. May be titr.  hepat.insuff., childr.und.18 yrs., safety in pregn.& lactat. not est.  when init.ther., concom.diuret. predispos.elderly to hyponatraem. &
       up in 50 mg increm.at 2wk. interv.to max.200 mg dly.  Side effects: Seroton.syndr., NMS, seiz., URTI, otit.med., GI disturbs.   SIADH, adeq. contracept.in women of child bear.potent., extrapy-
       OCD: Min.effect.dos. 50 mg dly. Dos.above 100 mg dly have no addit.  incl.oesophagit., neoplasm, lymphadenopathy, bld.dyscras., hypers-  ramid. disords., hostility/suicid.ideat.& self harm report.in childr.
       benef. Eff.observ.within 7 days with full activ.aft. 2-4 wks.  ens./allerg. react., hypothyroid., hyperprolactinaem., diab. mellit., hy-  Drug interactions: Pimozide plasma lev.incr., signific.chang.in some
       Contra-indications: MAOI, safety in pregn.not est., lactat., unstab.  percholesterolaem., hypo-/ hyperglycaem., convers.disord., depend.,   pharmacokinet. paramet. with diazepam & tolbutamide, St John’s
       epilepsy, concom.alcohol/ sumatriptan/tryptophan & fenfluramine,   sex. dysfunct., CNS/psych.effs, dizzin., somnol., syncope, headache,   Wort poss.potent serotonerg.potent, some pharmacokinet. paramet.
       safety & effic.in childr.not est.  tremor, movem.disords.incl. extrapyramid. sympts., convuls., invol.  change with diazepam/ tolbutamide, cimetidine decr.clear., incr. pro-
       Side-effects: GI disturbs., CNS effs, headache, trem., agitat.,   musc. contract., dyskines., coma, choreoathetos., S&S assoc. with   thrombin time with warfar.
       nervousn., anx., yawn., imp.conc., incr. sweat., dry mouth, fem.sex.  seroton.syndr.sometim.assoc.with concom. serotonerg.drugs., fev.,
       dysfunct., palpitat., paraesthes., hypoesthes., twitch., hyperton.,   tachycard., psychmot. restlessn., cerebrovasc.spasm, vis. disturbs.,   TEXINE, Novagen [P/S]
       rash, fatig., fev., hot flushes, back pain, thirst, myalg., micturit.freq/-  mydrias., incr.IOP & angle-clos.glauc.in predispos. pts., tinnit., palpi-  Paroxetine
       disords., menstr. disords., rhinit., pharyngit., vis.abnormalit., tinnit.,   tat., MI, bradycard., card.disord., QTc prolongat., Torsade de Point.,   Indications: Depress., obsess.compuls.disord., social phobia.,
       taste pervers., hyponatraem.main.assoc.with elderly/diuret.ther/  hot flush., hypertens., periph.ischaem., abnorm. bleed./ haemorrh.  panic disord.
       other concom.medicat.         incl.vagin., yawn., bronchosp., dyspn., epistax., hypo-/ hypervent., stri-  (S5) TABS, 42/1.2/0210
       Special precautions: Serotonin syndr.poss.with concom MAOI   dor, dysphon., hiccups, interstit.lung dis., saliv. hypersecret., haemo-  717561-001: 20 mg, 30, R182,65
       see contra-indicat., epilepsy/hist.of similar disords., ren./liv.impairm.,   tochez., pancreatit., ser.liv. events, hyperhidros., skin reacts. incl.Stev.   Dosage: Admin.once dly.in the morn.with food. Swallow whole.
       close supervis. of poss.suicide pts., risk/benef.of concom. electrocon-  Johns. syndr./epiderm.necrolys., oed., alopec., angioed., photosens.,   Treatm.for suff.per.ensur.pt. remain sympt.free.
       vuls. ther.not est., poss.activat.of hypoman./ mania, signific.weight   abnorm.skin odour/hair text., arthralg., myalg., musc.cramps/weakn./  Depress: 20 mg dly. If necess.may be incr.grad.in 10 mg increm.to
       loss poss., serum uric acid decr., hist.of recent MI or use in unstab.   twitch., osteoarthrit., back/ chest/ear pain, urin. incont., irreg. menstr.,   max.50 mg/day accord.to pt. respon.
       heart dis.not evaluat., limit.exper.in switch.of antidepress.agents.,   genit./ bone/micturit./tong./tooth disords., menorrhag., galactorrh.,   Panic disord: Recomm.dos: 40 mg dly. Init. 10 mg/ day incr.in
       monit.prothrombin time with concom.warfar., monit.concom Li lev-  gynaecomast., fatig., asthen., malaise, chills, pyrex., thirst, hernia,   10 mg increm.accord.to respons. Max. 60 mg/day. Low init.start.dos.
       els, high.incid. of serotonin assoc.S/E with meds.act.via serotenerg.   decr. meds.toler., incr. ALT/AST/ cholester., injury, vasodilat.proced.,   recomm.to minim. potent.worsen.of panic sympts.
       mechan., Parkinsons aggrav., abrupt discont., concom.highly prot.  sympt.foll.discont., poss.signif. weight loss.  OCD: Recomm.dos: 40 mg dly. Init.20 mg/day incr. in 10 mg increm.
       bound meds., extrapyramid. sympts.  Warnings and special precautions: Use for more than 12 wks.   to max. 60 mg/day.
       Drug interactions: Signific.chang.in some pharmacokinet.paramet.  not eval.in panic disord., re-eval.pt.dur.longt.use, adeq.contracept.in   Social phobia: Recomm.dos: 20 mg dly. Incr. dos. in 10 mg increm.
       of diazepam & tolbutamide, cimetidine decr.clear., incr. prothrombin   women of childbear. potent., concom.alcoh.not recomm., concom.   to max.dly.dos 60 mg as requir. accord.to respons.
       time with warfar., poss.interact.with meds. metabol.by cytochrome   Li/phenytoin/sumatriptan, avoid concom. other meds.enhanc.eff.of   Contraindications: MAOI, safety & effic.in childr. und.18 yrs.not est.,
       P450, poss.incr. plasma conc.of free med.with high.prot.bound meds.  serotonerg. neurotransmiss., monit.prothromb.time, QT prolongat.   concom.thioridazine, safety in pregn.& lactat.not est.
       SERRAPRESS, Pharma Dynamics [P/S]  risk fact., poss. activat.of mania/ hypoman., avoid in unstab.epilep.,   Side effects: Abnorm.bleed.predomin. of skin & mucous membr.
                                     monit.control. epilept., discont.if seiz.devel., taper dos. dur. discont.,
                                                                  (mostly ecchymos. also GI tract/ CNS & eye), SIADH, psych.disords.,
       Paroxetine                    concom.meds.affect.platel.funct., bleed. disord. hist., hyponatraem.  allerg.reacts., decr. appet., hyponatraem.esp.elderly, CNS effs., diz-
       Indications: Depress., obsess.compuls. disord., social phobia., panic   poss.due to SAIDH/ assoc. with elderly & diurets., vol.deplet.pts., dis-  zin., trem., extrapyramid.disords., convuls., seroton. syndr., asthen.,
       disord., gen.anx.disord.      cont. & init.appropr.ther.in case of symptom. hyponatraem., incr.bone   periph.oed., blurr.vis., ac glauc., yawn., urin.retent., sex.dysfunct., hy-
       (S5) TABS, 38/1.2/0069        fract.risk, dis./ condits. poss. affect.metab.or haemodynam.respons.,   perprolactinaem./ galactorrh., GI disords., elev. hepat. enzym., hepat.
       705122-001: 20 mg, 30, R174,55  not eval./used with MI/unstab.heart dis., monit.pts.for seroton./neu-  events somet.fatal, sweat., skin rash, photosens.reacts., mydrias.
       Dosage: Admin.once dly.in the morn. with food. Swallow whole.  rolept.malign.syndr.emerg. S&S, switch. from other antidepress./  Special precautions: Worsen.depress./emerg. suic. ideat./-behav
       Depress: 20 mg dly. If necess.may be incr. grad. in 10 mg increm.to   anti-obsession. esp. long act.agents, worsen.depress./emerg. suic.   risk in maj.depress./other psych./ non-psych.disords., monit.pts.esp.
       max. 50 mg/ day accord.to pt.response.  ideat./-behav risk in maj.depress./other psych./ non-psych.disords.,   dur early ther. & dos.chang.for clinic.worsen./suicid.ideat./ behav.,
       Panic disord: Recomm.dos: 40 mg dly. Init. 10 mg/day incr.in   monit.pts.esp.dur early ther.& dos chang.for clinic.worsen./suicid.  consid.chang.therap.regim./discont. if psych. sympts.occur which
       10 mg increm.accord.to respons. Max. 60 mg/day. Low init.start.dos.   ideat./behav., consid. chang.therap.regim./discont.if psych. sympts.   are sev./abrupt in onset/ not part of pres.sympts., withdr.grad.,
       recomm.to minim.potent.worsen.of panic sympts.  occur which are sev./abrupt in onset/ not part of pres.sympts., over-  mania hist., concom.neurolept./meds.incr.bleed. risk, known ten-
       OCD: Recomm.dos: 40 mg dly. Init. 20 mg/day incr. in 10 mg increm.  dos.risk, weak uricosur. eff., monit.for gluc.fluctuat.S&S esp.diab.pts.,   den.to bleed/predispos.condits., concom. alcoh.not advis., Li ther.,
       to max. 60 mg/day.            angl.-clos. glauc./hist.thereof, hostilit./suicid. ideat. & self harm re-  sev.ren./hepat. impairm., hostility/suic.ideat.& self harm report.in
       Social phobia: Recomm.dos: 20 mg dly. Incr. dos. in 10 mg increm.  port.in childr., withdr.sympt.on abrupt discont., no studies with ECT.  childr., elderly, discont.in cases of prolong.elev. LFT, admin.in ser.CV
       as requir.to max.dly.dos 40 mg accord.to response.  Drug interactions: Pimozide lev.incr., QT prolongat. &/ ventr.dys-  disords.not studied., withdr. sympts. with abrupt discont., epilep.,
       Gen.anx.disord: Recomm.dos: 20 mg dly. If unrespons.dos.may   rhythm.risk incr.with other meds. prolong.QT interv., poss.high. 5HT-  discont.ther. if seiz.devel., little clinic.exper.with ECT, narrow angle
       be incr.in 10 mg increm.of at least 1 wk.to max.50 mg/day ac-  assoc.S/E incid.with Li, reduc. plasma lev.& phenytoin conc. incr., CNS   glauc., concom.oral anticoags./procyclidine, concom.known meds.
       cord.to respons.              effs.with sumatriptan, potent. pharmacodynam. interact.with agents   metabol.enzym.inhibit.
       Contraindications: MAOI, safety & effic. in childr. und.18 yrs.not   enhanc. serotonerg. neurotransmiss.e.g. tryptophan/ fenfluramine/   Drug interactions: Toxic.of risperidone poss.incr, decr.plasma conc.
       est., concom.thioridazine & pimozide, safety in pregn.& lactat. not est.  fentanyl/5-HT antagon.or St John’s Wort, incr. prothromb.time with   with phenytoin, incr.adverse events with anticonvuls., poss.incr.bio-
       Side effects: Abnorm.bleed.predomin. of skin & mucous membr.  warfar., signif. chang.in some pharmacokinet.paramet.with diazepam   avail.with cimetidine, hepat.cytochrome P450 isozyme CYP2D6 re-
       (mostly ecchymos. also GI tract/ CNS & eye)., SIADH, psych.disords.,   & tolbutamide, cimetidine decr.clear., poss. fatal react.with MAOIs,   spons.for metabol.of debrisoquine & sparteine enhanc. plasma lev.of
       allerg. reacts., decr./incr.appetite., hyponatraem.esp.in elderly, CNS   incr.SS/NMS risk with concom.serotonerg.meds./meds.impair. sero-  concom.meds. metabol.by this isoenzyme., poss.seroton.syndr. with
       effs., convuls., seroton.syndr., extrapyramid. disords.in pts.using neu-  ton. metab./antipsychot./other dopamine agon.  tryptophan/MAOI/other serotonerg.agents, incr. risperidone toxic.
       rolept. meds., asthen., periph.oed., blurr.vis., ac glauc., yawn., urin.  with concom.use, poss.incr. bleed.in pres.of unalter.prothrob.times
       retent., sex.dysfunct., hyperprolactinaem. /galactorrh., GI disords.,   SERTRALINE-WINTHROP, Winthrop [P/S]  with warfar., incr. procyclidine plasma lev.& other anti-cholinergs.
       dry mouth, elev.hepat.enzyme., hepatit.poss.assoc. with jaund./liv.  Sertraline HCl.
       fail., sweat., skin rash, photosens. reacts., mydrias.  Indications: Maj.depress.disords.such as sngl. episod. & recurr.de-  XET 20, (Cipla Medpro) Zydus [P/S]
       Special precautions: Worsen.depress./ emerg. suicide ideat./-  press., obsess.compuls. disord., panic disord.with/-out agoraphob.  Paroxetine
       behav risk in maj.depress./other psych./non-psych. disords., monit.  (S5) TABS, A40/1.2/0742  Indications: Depress., OCD, social phobia, panic disord.
       pts.esp.dur early ther.& dos changes for clinic.worsen./ suicid.ideat./  709904-001: 50 mg, 30, R160,56  (S5) TABS, 39/1.2/0216
       behav., consid.chang.therapeut. regim/discont.if psych.sympts.oc-  Dosage: Admin as sngl.dly.dos.  705633-001: 20 mg, 30, R144,74
       cur which are sev./abrupt in onset/not part of pres.sympts., withdr.   Depress: Init. 50 mg dly. Usual therapeut.dos. 50 mg dly. May be titr.  Dosage: Admin.once dly.in the morn.with food. Swallow whole.
       sympts.with abrupt discont., mania hist., concom.neurolept./meds.  up in 50 mg increm.at 2 wk. interv.to max.150-200 mg/day.  Depress: Recom.init.dos.20 mg dly. If necess. may be incr.grad.in
       incr.bleed.risk, known tenden.to bleed/predispos.condits./concom.  OCD: Eff.observ.within 1 wk.& full activ.aft. 2-4 wks. Min.effect.dos.   10 mg increm.to max.50 mg/ day accord. to pt.response.
       oral anticoags., concom.alcoh.not advis., Li ther., concom.digox.&   50 mg dly. Incr.above 100 mg dly have no addit.benef.  Panic disord: Recomm.dos: 40 mg dly. Init. 10 mg / day incr.in 10 mg
       sumatriptan, reduc.procyclidine dos.in case of anticholinerg.effs.,   Panic disord: Re-eval.usefulness.periodic. Init. 25 mg dly.incr.to 50   increm. Max.60 mg/ day. Low init.start.dos.is recomm.
       hostility/ suicide ideat.& self harm report.in childr., elderly, sev.ren./  mg dly.aft.1 wk. Min. recomm. effect.dos: 50 mg dly. This regim.re-  OCD: Recomm.dos: 40 mg dly. Init.20 mg/day incr. in 10 mg increm.
       hepat.impairm., discont.in cases of prolong. elev.LFT, admin.in ser.CV   duc. freq.of early treatm.emergent.S/E.  to max. 60 mg/day.
       disords.not studied., epilep., little clinic.exper. with ECT, narrow angle   Contra-indications: MAOI, safety in childr.und. 18 yrs.not est.,   Social phobia: Recomm.dos: 20 mg dly. Incr. grad.if necess.in 10
       glauc., monit.concom.theophyll. ser.conc.  concom.pimozide, alcoh.not advis., agents enhanc.serotonerg.   mg increm.to max.60 mg accord.to response
       Drug interactions: Toxic of risperidone poss. incr, poss.incr.bioavail.  neurotransmiss. eg.tryptophan& fenfluramine not advis., safety in   Contra-indications: MAOI, safety & effic.in childr.und.18 yrs.not
       with cimetidine (drug metabol.inhibit.), decr.bioaval.with phenytoin   pregn.& lactat.not est.,  est., concom.thioridazine, safety in pregn.& lactat.not est.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page47.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page43.html">43</a>&nbsp;&nbsp;&nbsp;<a href="page44.html">44</a>&nbsp;&nbsp;&nbsp;<a href="page45.html">45</a>&nbsp;&nbsp;&nbsp;<a href="page46.html">46</a>&nbsp;&nbsp;&nbsp;<a href="page47.html">47</a>&nbsp;&nbsp;&nbsp;<a href="page48.html">48</a>&nbsp;&nbsp;&nbsp;<a href="page49.html">49</a>&nbsp;&nbsp;&nbsp;<a href="page50.html">50</a>&nbsp;&nbsp;&nbsp;<a href="page51.html">51</a>&nbsp;&nbsp;&nbsp;<a href="page52.html">52</a>&nbsp;&nbsp;&nbsp;<a href="page53.html">53</a>
             </td>
             <td width="35%"><a href="page49.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page49.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
